Cargando…

A review of laser and light therapy in melasma

Melasma is a dysregulation of the homeostatic mechanisms that control skin pigmentation and excess pigment is produced. Traditional treatment approaches with topical medications and chemical peels are commonly used but due to the refractory and recurrent nature of melasma, patients often seek altern...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, M.K., Yang, F.C., Cho, B.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418955/
https://www.ncbi.nlm.nih.gov/pubmed/28492049
http://dx.doi.org/10.1016/j.ijwd.2017.01.004
_version_ 1783234152362934272
author Trivedi, M.K.
Yang, F.C.
Cho, B.K.
author_facet Trivedi, M.K.
Yang, F.C.
Cho, B.K.
author_sort Trivedi, M.K.
collection PubMed
description Melasma is a dysregulation of the homeostatic mechanisms that control skin pigmentation and excess pigment is produced. Traditional treatment approaches with topical medications and chemical peels are commonly used but due to the refractory and recurrent nature of melasma, patients often seek alternative treatment strategies such as laser and light therapy. Several types of laser and light therapy have been studied in the treatment of melasma. Intense pulsed light, low fluence Q-switched lasers, and non-ablative fractionated lasers are the most common lasers and light treatments that are currently performed. They all appear effective but there is a high level of recurrence with time and some techniques are associated with an increased risk for postinflammatory hyper- or hypopigmentation. The number and frequency of treatments varies by device type but overall, Q-switched lasers require the greatest number of treatment applications to see a benefit. Vascular-specific lasers do not appear to be effective for the treatment of melasma. Ablative fractionated lasers should be used with caution because they have a very high risk for postinflammatory hypo- and hyperpigmentation. The use of nonablative fractionated laser treatments compared with other laser and light options may result in slightly longer remission intervals. Picosecond lasers, fractional radiofrequency, and laser-assisted drug delivery are promising future approaches to treat melasma. The goal of this review is to summarize the efficacy and safety of the most commonly used laser and light therapies to treat melasma, briefly present future laser-based treatment options for patients with melasma, and provide recommendations for treatment on the basis of the reviewed information.
format Online
Article
Text
id pubmed-5418955
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54189552017-05-10 A review of laser and light therapy in melasma Trivedi, M.K. Yang, F.C. Cho, B.K. Int J Womens Dermatol Review Melasma is a dysregulation of the homeostatic mechanisms that control skin pigmentation and excess pigment is produced. Traditional treatment approaches with topical medications and chemical peels are commonly used but due to the refractory and recurrent nature of melasma, patients often seek alternative treatment strategies such as laser and light therapy. Several types of laser and light therapy have been studied in the treatment of melasma. Intense pulsed light, low fluence Q-switched lasers, and non-ablative fractionated lasers are the most common lasers and light treatments that are currently performed. They all appear effective but there is a high level of recurrence with time and some techniques are associated with an increased risk for postinflammatory hyper- or hypopigmentation. The number and frequency of treatments varies by device type but overall, Q-switched lasers require the greatest number of treatment applications to see a benefit. Vascular-specific lasers do not appear to be effective for the treatment of melasma. Ablative fractionated lasers should be used with caution because they have a very high risk for postinflammatory hypo- and hyperpigmentation. The use of nonablative fractionated laser treatments compared with other laser and light options may result in slightly longer remission intervals. Picosecond lasers, fractional radiofrequency, and laser-assisted drug delivery are promising future approaches to treat melasma. The goal of this review is to summarize the efficacy and safety of the most commonly used laser and light therapies to treat melasma, briefly present future laser-based treatment options for patients with melasma, and provide recommendations for treatment on the basis of the reviewed information. Elsevier 2017-03-21 /pmc/articles/PMC5418955/ /pubmed/28492049 http://dx.doi.org/10.1016/j.ijwd.2017.01.004 Text en © 2017 Women's Dermatologic Society. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Trivedi, M.K.
Yang, F.C.
Cho, B.K.
A review of laser and light therapy in melasma
title A review of laser and light therapy in melasma
title_full A review of laser and light therapy in melasma
title_fullStr A review of laser and light therapy in melasma
title_full_unstemmed A review of laser and light therapy in melasma
title_short A review of laser and light therapy in melasma
title_sort review of laser and light therapy in melasma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418955/
https://www.ncbi.nlm.nih.gov/pubmed/28492049
http://dx.doi.org/10.1016/j.ijwd.2017.01.004
work_keys_str_mv AT trivedimk areviewoflaserandlighttherapyinmelasma
AT yangfc areviewoflaserandlighttherapyinmelasma
AT chobk areviewoflaserandlighttherapyinmelasma
AT trivedimk reviewoflaserandlighttherapyinmelasma
AT yangfc reviewoflaserandlighttherapyinmelasma
AT chobk reviewoflaserandlighttherapyinmelasma